A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse

European Journal of Neurology

Volumn 13, Issue 9, 2006, Pages 1009-1013

  Cevoli, S ^a   Mochi, M ^a   Scapoli, C ^b   Marzocchi, N ^c   Pierangeli, G ^a   Pini, L A ^c   Cortelli, P ^a   Montagna, P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chronic headache; Dopamine; Drug abuse; Genetics

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANALGESIC AGENT; CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; NONSTEROID ANTIINFLAMMATORY AGENT; TRYPTOPHAN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG ABUSE; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE AURA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CATECHOL O-METHYLTRANSFERASE; CHRONIC DISEASE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEADACHE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D4; SUBSTANCE-RELATED DISORDERS;

EID: 33747833151     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01415.x     Document Type: Article

References (26)

1. Vandenbergh DJ, Rodriguez LA, Hivert E, et al. Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: no interaction with functional alleles of the catechol-O-methyltransferase (COMT) gene. American Journal of Medical Genetics 2000; 96: 678-683.
2. Schinka JA, Letsch EA, Crawford FC. DRD4 and novelty seeking: Results of meta-analyses. American Journal of Medical Genetics 2002; 114: 643-648.
3. Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994; 11: 195-200.
4. Tiihonen J, Kuikka J, Bergstrom K, et al. Altered striatal dopamine re-uptake sites in habitually violent and non violent alcoholics. Nature Medicine 1995; 1: 654-657.
5. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. American Journal of Psychiatry 1998; 155: 474-478.
6. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology 1999; 18: 14-20.
7. Sabol SZ, Nelson ML, Fisher C, et al. A genetic association for cigarette smoking behaviour. Health Psychology 1999; 18: 7-13.
8. Jorm AF, Henderson AS, Jacomb PA, et al. Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. American Journal of Medical Genetics 2000; 96: 331-334.
9. Laine TP, Ahonen A, Rasanen P, Tiihonen J. Dopamine transporter density and novelty seeking among alcoholics. Journal of Addictive Diseases 2001; 20: 91-96.
10. Saito T, Lachman HM, Duaz L, et al. Analysis of monoammino oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Research 2002; 109: 113-119.
11. Mathew NT, Stubits E, Nigam MP. Transformed or evolutive migraine. Headache 1987; 22: 66-68.
12. Russell MB, Ostergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia 1999; 19: 207-210.
13. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache. The Head-HUNT study. Neurology 2003; 61: 160-164.
14. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Molecular Medicine 1998; 4: 14-21.
15. Van Tol HHM, Wu CM, Guan HC, et al. Multiple dopamine D4 receptor variants in the human population. Nature 1992; 350: 610-614.
16. Heinz A, Goldman D, Jones DW, et al. Genotypes influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000; 22: 133-139.
17. Hotamisligil GS, Breakefield XO. Human monoamine oxidase A gene determines levels of enzyme activity. American Journal of Human Genetics 1991; 49: 383-392.
18. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
19. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004; 24: 1-160.
20. Mochi M, Cevoli S, Cortelli P, et al. A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta- hydroxylase genes. Neurological Sciences 2003; 23: 301-305.
21. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48: 361-372.
22. Schneider S, Kueffer JM, Roessli D, Excoffier L. Arlequin ver 1.1: A Software for Population Genetic Data Analysis. University of Geneva, Switzerland: Genetics and Biometry Laboratory, 1997.
23. Gainetdinov RR, Jones SR, Caron MG. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biological Psychiatry 1999a; 46: 303-311.
24. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-612.
25. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999b; 283: 397-401.
26. Silberstein SD, Peres MF, Hopkins MM, Shechter AL, Young WB, Rozen TD. Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache 2002; 42: 515-518.